Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. implant tissue
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Implant Tissue Articles & Analysis

40 news found

CD Formulation Newly Launches 100+ Raw Materials for Preparation of Microspheres and Microneedles

CD Formulation Newly Launches 100+ Raw Materials for Preparation of Microspheres and Microneedles

Considering this, we decided to introduce such a new product line, with different material sizes, shapes, and compositions, to help researchers and manufacturers achieve the desired drug release profile and tissue penetration,” said the Marketing Director of CD Formulation. ...

ByCD Formulation


Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant

Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant

Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced that the NUsurface® Meniscus Implant has been granted a Breakthrough Device Designation from the U.S. ...

ByActive Implants LLC


Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego

Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego

Active Implants, a company that develops orthopedic implant solutions, today announced that the company’s SUN (Safety Using NUsurface) trial is now underway in San Diego. ...

ByActive Implants LLC


100th Patient Enrolled in Clinical Trials for Active Implants’ NUsurface Meniscus Implant

100th Patient Enrolled in Clinical Trials for Active Implants’ NUsurface Meniscus Implant

Active Implants, LLC, a company that develops orthopedic implant solutions, today announced enrollment of the 100th patient in clinical trials evaluating the NUsurface® Meniscus Implant for the treatment of persistent knee pain caused by injured or deteriorating meniscus tissue. ...

ByActive Implants LLC


Grossmont Orthopaedic Medical Group Performs First Meniscus Replacement in San Diego with NUsurface Meniscus Implant

Grossmont Orthopaedic Medical Group Performs First Meniscus Replacement in San Diego with NUsurface Meniscus Implant

Hacker, an expert in arthroscopic surgery, total joint replacements, sports medicine and fracture care, and Active Implants, a company that develops orthopedic implant solutions, today announced that the first meniscus replacement procedure in San Diego has been performed. ...

ByActive Implants LLC


Photodisinfection successfully eradicates pathogens associated with replacement joint infections

Photodisinfection successfully eradicates pathogens associated with replacement joint infections

A research team in Zurich, Switzerland has presented results from an in vitro study showing that photodisinfection achieved >99.99% eradication (4-7 log10 kill) of the key pathogens in biofilms associated with implantable joint infections, with no reported regrowth. These results were presented at the recent Swiss Society for Microbiology (SSM) Annual Congress 2022 in ...

ByOndine Biomedical Inc


3DBio Therapeutics and the Microtia-Congenital Ear Deformity Institute Conduct Human Ear Reconstruction Using 3D-Bioprinted Living Tissue Implant in a First-in-Human Clinical Trial

3DBio Therapeutics and the Microtia-Congenital Ear Deformity Institute Conduct Human Ear Reconstruction Using 3D-Bioprinted Living Tissue Implant in a First-in-Human Clinical Trial

3DBio Therapeutics (3DBio), a clinical-stage regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant, an investigational, patient-matched, 3D-bioprinted living tissue ear implant. ...

By3DBio Therapeutics


enVVeno Medical Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update

enVVeno Medical Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update

In early 2022, the Company announced that it had received ISO 13485 certification for its Irvine facility covering the design, development, and manufacture of tissue based implantable medical devices. Progress has continued on a second product for the treatment of venous disease which the Company expects to announce in mid-2022. ...

ByenVVeno Medical


FDA clears Sonavex’s ultrasound blood flow monitor

FDA clears Sonavex’s ultrasound blood flow monitor

The EchoSure system is cleared for use with the company’s EchoMark bioresorbable tissue markers, which got the agency’s nod in June. “The key goal is to be able to detect the problems associated with microvascular and vascular surgeries with high risk of post-op complications,” said Sonavex CEO David Narrow. ...

BySonavex, Inc.


Healthium in collaboration with Abhinav Bindra Foundation Trust (ABFT) inaugurates the ‘Sport of Life’, Bengaluru

Healthium in collaboration with Abhinav Bindra Foundation Trust (ABFT) inaugurates the ‘Sport of Life’, Bengaluru

As a part of this initiative, Healthium will aid in the treatment of sports injuries with free arthroscopy implants. Bhaichung Bhutia, torchbearer of Indian Football in the international arena, Abhinav Bindra, India's first Individual Olympic gold medalist and Founder, ABFT, Prof. ...

ByHealthium Medtech Limited


Xeltis receives €15M funding from EIC Accelerator

Xeltis receives €15M funding from EIC Accelerator

XABG is a restorative, synthetic blood vessel device that turns into a living blood vessel when colonised by patient’s own tissue, following implantation. It is designed to overcome the limitations and complications resulting from patient’s vein harvesting, which is the current option in CABG surgery. ...

ByXELTIS BV


Poietis and Assistance Publique – Hôpitaux de Marseille (AP-HM) annouce the first installation of a 3D bioprinting platform for manufacturing implantable biological tissues in hospitals

Poietis and Assistance Publique – Hôpitaux de Marseille (AP-HM) annouce the first installation of a 3D bioprinting platform for manufacturing implantable biological tissues in hospitals

The objective is now to start the first clinical trial of a 3D printed human tissue. Poietis, a pioneer in bioprinting, and the Assistance Publique – Hôpitaux de Marseille (« AP-HM ») announced today the installation of the first bioprinting platform compatible with the regulatory requirements surrounding the manufacture of ...

ByPoietis


Xeltis lands €15 million European financing from EIB

Xeltis lands €15 million European financing from EIB

” Xeltis’ devices are vascular grafts and heart valves designed to turn into living valves and vessels by harnessing the body’s natural healing process and by facilitating tissue formation once implanted. Xeltis’ devices are made of supramolecular polymers shaped — through a process called electrospinning — into a ...

ByXELTIS BV


World’s First “Artificial Meniscus” Available in Israel

World’s First “Artificial Meniscus” Available in Israel

Active Implants LLC, a company that develops orthopedic implant solutions, today announced that two patients in Israel have undergone knee surgery for the company’s NUsurface® Meniscus Implant – the first “artificial meniscus” to be marketed in the Middle East. ...

ByActive Implants LLC


First Implants of PROPEL Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

First Implants of PROPEL Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

Another benefit of the PROPEL Contour implant is that it does not need to be removed and will dissolve after approximately 4-6 ...

ByIntersect ENT, Inc.


Active Implants’ NUsurface Meniscus Implant Provides Statistically Superior Pain Relief

Active Implants’ NUsurface Meniscus Implant Provides Statistically Superior Pain Relief

Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced two-year results of the MERCURY study, which showed that the company’s NUsurface® Meniscus Implant provides statistically superior pain relief beginning at six months compared to non-surgical therapy. ...

ByActive Implants LLC


First Five Patients Successfully Treated with atHeart Medical’s Novel reSept Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

First Five Patients Successfully Treated with atHeart Medical’s Novel reSept Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

“I am pleased to be a part of this study and advance therapy options for septal defects that leave a minimal footprint behind. The reSept ASD Occluder implanted easily and had a successful outcome with no residual shunts,” commented Dr. ...

ByatHeart Medical


Xeltis initiates first-ever pivotal trial of a synthetic restorative pulmonary heart valve

Xeltis initiates first-ever pivotal trial of a synthetic restorative pulmonary heart valve

Following implantation, Xeltis’ synthetic restorative pulmonary heart valves evolve into fully functioning, natural heart valves through colonization by the patient’s own tissue. The implants’ porous micro-structure enables the patient’s own tissue to populate it and naturally form a new heart valve that ...

ByXELTIS BV


Nalu Micro-Implantable Pulse Generator Receives Award for Implanted Medical Device Innovation and Health Benefits

Nalu Micro-Implantable Pulse Generator Receives Award for Implanted Medical Device Innovation and Health Benefits

(“Nalu”), a California-based company that has successfully miniaturized neurostimulation implants for chronic intractable pain management indications, announces its Nalu micro-Implantable Pulse Generator (mIPG) was named the Implant and Tissue-Replacement device Gold Winner at the 2021 Medical Design Excellence Awards ...

ByNalu Medical, Inc.


Aspect Biosystems And Jsr Corporation Enter Collaboration To Develop Bioprinted Vascularized Tissues For Regenerative Medicine

Aspect Biosystems And Jsr Corporation Enter Collaboration To Develop Bioprinted Vascularized Tissues For Regenerative Medicine

This collaboration builds on the existing partnership between the two companies and will see the combining of Aspect’s proprietary microfluidic 3D bioprinting platform with JSR’s advanced materials technology to develop implantable vascularized tissues for kidney regeneration and other applications in regenerative medicine. The vascularized ...

ByAspect Biosystems Ltd.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT